Home › Linfoma › Distretto di Columbia › Washington
Studi clinici su Linfoma a Washington, DC
23 studi su Linfoma cercano partecipanti presso sedi a Washington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
In reclutamentoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
In reclutamentoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
In reclutamentoFase 2
- Maryland Oncology Hematology, Silver Spring · a 7 mi di distanza
Collection of Tissue Samples for Cancer Research
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
In reclutamentoFase 1/2
- Children's National Medical Center, Washington D.C.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
In reclutamentoFase 3
- Research Site, Bethesda · a 7 mi di distanza
Sample Collection and Tracking for the Developmental Therapeutics Clinic
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
In reclutamentoStudio osservazionale
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
In reclutamentoFase 3
- Georgetown University, Washington D.C.
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
In reclutamentoFase 1/2
- Medstar Georgetown University Hospital, Washington D.C.
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
In reclutamentoFase 2
- Georgetown University (Data Collection Only), Washington D.C.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
In reclutamentoFase 3
- MedStar Georgetown University Hospital, Washington D.C.
Vaccine Responses in Patients With B Cell Malignancies
In reclutamentoFase 4
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Mosaic Trial for Stem Cell Transplant Recipients
In reclutamento
- Georgetown University School of Medicine, Washington D.C.
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
In reclutamentoFase 1
- National Institute of Health, Bethesda · a 7 mi di distanza
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
In reclutamentoStudio osservazionale
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Studi su Linfoma in altre città
- Houston, TX34 studi
- Boston, MA33 studi
- New York City, NY33 studi
- Baldwin Park, CA21 studi
- Chicago, IL20 studi
- Durham, NC17 studi
- St. Louis, MO15 studi
- Philadelphia, PA15 studi
- Cleveland, OH14 studi
- Edison, NJ12 studi
- Atlanta, GA12 studi
- Seattle, WA12 studi
Altri studi a Washington
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule55 studi
- Cancro al seno46 studi
- Cancro metastatico43 studi
- Cancro ai polmoni41 studi
- Cancro alla prostata38 studi
- Obesità33 studi
- Cancro colorettale29 studi
- Malattie cardiovascolari28 studi
- Cancro della vescica26 studi
- Leucemia mieloide acuta24 studi
- Cancro ovarico23 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.